Evidence map›Paper›PMID 27487748›Full record

ReviewHamostaseologie2016

Inherited dysfunctional platelet P2Y

Anna Lecchi, Eti A Femia, Silvia Paoletta, Arnaud Dupuis, Philippe Ohlmann, Christian Gachet, Kenneth A Jacobson, Katharina Machura, Gian M Podda, Barbara Zieger and 1 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Hamostaseologie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Ticagrelor - toward more efficient platelet inhibition and beyond.Therapeutics and clinical risk management · 2018
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Anna Lecchi
Eti A Femia
Silvia Paoletta
Arnaud Dupuis
Philippe Ohlmann
Christian Gachet
Kenneth A Jacobson
Katharina MachuraKatharina Machura, University Medical Center, Freiburg - Department of Pediatrics and Adolescent Medicine, Breisacher-Str. 66, 79106 Freiburg, Germany, Tel. +49/(0)761/27 06 37 10, E-mail: katharina.machura@uniklinik-freiburg.de.
Gian M Podda
Barbara Zieger
Marco Cattaneo
Établissement Français du Sang · FRNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity Medical Center Freiburg · DEAOL (United States) · USAzienda Socio Sanitaria Territoriale Santi Paolo e CarloFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITInserm · FRUniversity of Freiburg · DE

Funding

Development Of P2Y Receptor LigandsZIADK031116 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JACOBSON, KENNETH ALAN · 2009 to 2025
$8.9M
Intramural NIH HHS ZIA DK031116
6 · The paper itself

Abstract

The platelet adenosine 5'-diphosphate (ADP) receptor P2Y

Indexed as

Blood Platelet DisordersGenetic Predisposition to DiseaseHemorrhageHumansModels, GeneticModels, ImmunologicalMutationPolymorphism, Single NucleotideReceptors, Purinergic P2Y12Receptors, Purinergic P2Y12mutationP2Y12 receptorPlatelets

Identifiers

PMID27487748
PMCPMC5099093
OpenAlexW2481975106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.